NCT07813611Not yet recruiting
Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic Dermatitis
Microbiological Profile of Secondary Bacterial Infections and Nasal Colonization in Patients With Scabies and Atopic Dermatitis: A Prospective Observational Study
Source: ClinicalTrials.gov · Last updated 15 Sept 2026
Brief summary (registry, in English)
This prospective observational study will evaluate the microbiological profile of secondary bacterial infection and nasal colonization in participants with scabies or atopic dermatitis. Bacteria isolated from impetiginized skin lesions and nasal swabs will be compared, and antimicrobial susceptibility patterns will be assessed. Healthy participants without an inflammatory skin disease or signs of infection will provide nasal swabs as a control group. Patients will be followed on days 7 and 14 to assess clinical response and related clinical measures.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 51 (estimated)
- First submitted
- 4 Sept 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 31 Mar 2027
- Lead sponsor
- Istanbul Medeniyet University
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT07813611
What you commit to
- Study type: Observational
- Planned participants: 51
- From 1 Oct 2026 to the primary completion date, 31 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Systemic or topical antibiotic use within the previous 14 days.
Other illness
- Active nasal infection or nasal symptoms.
- History of nasal surgery or anatomic nasal deformity.
- TEST DRAFT NOTE: The source protocol contains wording that may conflict with inclusion of healthy controls; the final eligibility text must be reconciled with the ethics-approved protocol before release.
Who the study is looking for
- Scabies group: dermatologist-confirmed scabies and an active impetiginized skin lesion.
- Atopic dermatitis group: dermatologist-confirmed atopic dermatitis and an active impetiginized skin lesion.
- Healthy control group: no inflammatory skin disease or clinical signs of infection.
- Written informed consent (and appropriate parent/guardian permission when applicable).
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Test Study Site - Replace Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.